Knowledge of one's fibroglandular breast density is important, because high density increases the risk of cancer and decreases the accuracy of mammograms. A comparision of a small breast cancer found in a patient without dense breast tissue leftand a tumor found in a woman with dense fibroglandular tissue. SecondLook Premier software from iCAD marks potential mass oval and calcifications rectangle on left breast with dense tissue.
Women with a certain gene mutation are among the high-risk patients for breast cancer. With a magnetic resonance tomography MRT it is possible to detect tissue with measurable active blood supply which indicates an increased breast cancer risk. The molecular biologist and radiologist, Barbara Bennani-Baiti and the radiologist Pascal Baltzer of the Clinic for Radiology and Nuclear Medicine of MedUni Vienna are now exploring whether tissue with active blood supply visible with MRT could indicate a grater risk in those patients without gene mutation.
The idea was originally met with scepticism, but consensus now is that it is indeed a true risk element and of interest to screening mammography. Essentially, breast density is a comparison of the relative amounts of fat versus fibroglandular tissues in the breast. Fibroglandular parenchyma, basically means breast tissue.
Metrics details. Studies have consistently shown a strong relationship between breast cancer risk and mammographic parenchymal patterns, typically assessed by percent mammographic density. This paper will review the advancing role of mammographic texture analysis as a potential novel approach to characterize the breast parenchymal tissue to augment conventional density assessment in breast cancer risk estimation.
Objectives: We aimed to investigate the BPE patterns in benign and malignant breast lesions and in pre-menopausal and post-menopausal women. Methods: Inconsecutive pre-menopausal or post-menopausal patients underwent breast MRI with different indications were examined. Subjects with the history of breast surgery, radiotherapy, or chemotherapy were excluded.
This article describes the historical classifications of breast density. Pioneers in classification of density include Leborgne in and Wolfe inwho described an increased risk of breast cancer in radiographically dense breast. The first qualitative classification of mammographic density patterns was described by Wolfe in
A case-control study was conducted to assess whether certain "high-risk" mammographic parenchymal patterns are associated with the increased occurrence of breast cancer in postmenopausal women. Patients in the case group included women with histologically confirmed breast cancer; subjects in the control group included women with fibrocystic breast disease and women with clinically normal breasts. All mammographic results were evaluated "blindly" by a radiologist who classified the breast parenchyma into "high-risk" and "low-risk" categories according to the criteria proposed by Wolfe.
Materials and Methods: Two-view digital mammograms of consecutive women mean age - Cancer statistics, CA Cancer J Clin ; Quantitative assessment of mammographic breast density: Relationship with breast cancer risk.
Please take this quick survey to tell us about what happens after you publish a paper. Current Breast Cancer Reports. Breast density, or the amount of fibroglandular tissue in the breast, has become a recognized and independent marker for breast cancer risk.
Dense breast tissue is detected on a mammogram. Additional imaging tests are sometimes recommended for women with dense breasts. If a recent mammogram showed you have dense breast tissue, you may wonder what this means for your breast cancer risk. Doctors know dense breast tissue makes breast cancer screening more difficult and it increases the risk of breast cancer.